Detalhe da pesquisa
1.
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma.
Blood
; 139(16): 2471-2482, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134130
2.
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression.
Blood
; 137(26): 3604-3615, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649772
3.
CNV Radar: an improved method for somatic copy number alteration characterization in oncology.
BMC Bioinformatics
; 21(1): 98, 2020 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32143562
4.
Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
Nat Immunol
; 9(12): 1364-70, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18997792
5.
Copper 64-labeled daratumumab as a PET/CT imaging tracer for multiple myeloma.
Blood
; 131(7): 741-745, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301755
6.
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.
Blood
; 132(20): 2154-2165, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181174
7.
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Blood
; 132(6): 587-597, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29884741
8.
Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma.
Haematologica
; 105(4): 1055-1066, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221783
9.
c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma.
Eur J Haematol
; 105(1): 35-46, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145111
10.
Comprehensive molecular profiling of 718 Multiple Myelomas reveals significant differences in mutation frequencies between African and European descent cases.
PLoS Genet
; 13(11): e1007087, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29166413
11.
Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.
Am J Hematol
; 94(12): 1364-1373, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31571261
12.
RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.
Br J Haematol
; 177(1): 80-94, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369725
13.
Initial genome sequencing and analysis of multiple myeloma.
Nature
; 471(7339): 467-72, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21430775
14.
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
Cancer Cell
; 12(2): 131-44, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17692805
15.
Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.
Blood
; 120(5): 1060-6, 2012 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22529291
16.
Clonal competition with alternating dominance in multiple myeloma.
Blood
; 120(5): 1067-76, 2012 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22498740
17.
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma.
Blood Cancer Discov
; 5(1): 56-73, 2024 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934799
18.
RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5.
Blood
; 117(14): 3847-57, 2011 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21289309
19.
Alternative splicing in multiple myeloma is associated with the non-homologous end joining pathway.
Blood Cancer J
; 13(1): 16, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670103
20.
Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing.
Life Sci Alliance
; 6(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328595